Founded in 2001 by Mr. Dhirajlal Kotadia, Sahajanand Medical Technologies Ltd. is a medical device company focused on Class III and Class C/D devices, primarily in the fields of vascular and structural heart intervention. The company was the first globally to receive CE certification for a drug-eluting stent (DES) with a biodegradable polymer—Infinnium.
Sector
Sahajanand operates two R&D centers—one in India and one in Thailand—supported by a team of 102 professionals, including biomedical engineers and clinical research specialists. The company has built a robust intellectual property base, with 102 patents granted globally and 71 pending patent applications, along with five design registrations in India.
P/E Ratio
-
Security Type
-
Face Value
-
Incorporation Year
-
Employee Count
-
Brand Name
-
Product Portfolio
Vascular Intervention (VI): Includes coronary stents and balloons for minimally invasive blood vessel treatments.
Structural Heart (SH): Covers advanced technologies such as Transcatheter Aortic Valve Implantation (TAVI) and Occluders.
Other Products: Includes renal stents, peripheral Drug-Coated Balloons (DCBs), and selected trading products.